MouSensor, Inc.
MouSensors provide the first genetic platform for smell pharmacology to assist humans in scent detection tasks such as non-invasive cancer diagnosis, Tuberculosis identification, explosives detection etc. Team: Paul Feinstein, PhD. – Co-founder Charlotte D’Hulst, PhD. – Co-founder
Read MoreBrainFUS
BrainFUS is a patent ultrasound medical system to treat brain disease by disrupting the blood-brain barrier and assisting drug delivery noninvasively. Team: Shih-Ying Wu, PhD
Read MoreSonify Bioscience
Sonify is building a device that uses low-intensity ultrasound and RF radiometry to deliver controlled, remote hyperthermia to a wide array of superficial tumors. Team: Dr. Miriam S. Boer, PhD. – Founder
Read MorePatch Benefit
Patch is a healthcare concierge for employees. We work one-on-one with individuals to find them doctors, schedule their appointments and manage their prescriptions. Team: Loune Calixte, CEO
Read MoreLanyard Therapeutics
We are developing a first-in-class and best-in-class biologics for mechanism-based cancer immunotherapy Lanyard Theraputics Team: Ming Li Dr. Xiuyan Wang Douglas Zhang
Read MoreRecoverLINK
RecoverLINK is a mobile health technology that transforms how heart failure patients experience care after hospital discharge. RecoverLINK Team: Christina Anzalone Laurie Thackeray
Read More6Degrees
Crescent’, a revolutionary arm band, allows disabled individuals to operate any blue-tooth enabled device and re-integrate with the work force and social media‘Crescent’, a revolutionary arm band, allows disabled individuals to operate any blue-tooth enabled device and re-integrate with the work force and social media. 6Degrees Team: Aryeh Katz Miri Berger
Read MoreBioZAP
Our technology is a 3D microfluidic tumor array platform which will be used for personalized medicine by evaluating the therapeutic response of biopsy samples. Zeynep Dereli-Korkut
Read MoreGirihlet
Our innovation is a method of purifying and sequencing mitochondrial DNA (mtDNA). The objective is to develop mtDNA biomarkers for neurological disorders and drug-resistance in cancer. Girihlet Team: Anitha Jayaprakash Ravi Sachidanandam
Read MoreImmuneTarget, Inc.
Our mission at ImmuneTarget is to develop novel Rel/NF-kB inhibitor drugs for cancer and autoimmune diseases. ImmuneTarget, Inc. Team: Hsiou-Chi Liou Samedy Ouk
Read More